Literature DB >> 15481347

Extrahepatic manifestations of chronic hepatitis B.

Steven-Huy B Han1.   

Abstract

Several extrahepatic manifestations are associated with chronic HBV infection, many with significant morbidity and mortality. The cause of these extrahepatic manifestations is generally believed to be immune mediated. PAN is a rare, but serious, systemic complication of chronic HBV affecting the small- and medium-sized vessels. PAN is seen more frequently in North American and European patients and rarely in Asian patients. PAN ultimately involves multiple organ systems, some with devastating consequences, though the hepatic manifestations are often more mild. The optimal treatment of HBV-associated PAN is thought to include a combination of antiviral and immunosuppressive therapies. HBV-associated GN occurs mainly in children, predominantly males, in HBV endemic areas of the world, but is only occasionally reported in the United States. In children, GN is usually self-limited with only rare progression to renal failure. In adults, the natural disease course of GN may be more relentless, slowly progressing to renal failure. Immunosuppressive therapy in HBV-related GN is not recommended, but antiviral therapy with alpha-interferon has shown promise. The serum-sickness like "arthritis-dermatitis" prodrome is seen in approximately one third of patients acquiring HBV. The joint and skin manifestations are varied, but the syndrome spontaneously resolves at the onset of clinical hepatitis with few significant sequelae. Occasionally, arthritis following the acute prodromal infection may persist; however, joint destruction is rare. The association between HBV and mixed essential cryoglobulinemia remains controversial; but a triad of purpura, arthralgias, and weakness, which can progress to nephritis, pulmonary disease, and generalized vasculitis, has characterized the syndrome. Finally, skin manifestations of HBV infection typically present as palpable purpura. Though papular acrodermatitis of childhood has been reported to be caused by chronic HBV, this association remains controversial.

Entities:  

Mesh:

Year:  2004        PMID: 15481347     DOI: 10.1016/j.cld.2004.02.003

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  34 in total

1.  Rapid improvement of distal vasculitis in PAN related to hepatitis B with alprostadil infusion: a case report.

Authors:  Mie-Jin Lim; Seong Ryul Kwon; Seunghee Lee; Won Park
Journal:  Rheumatol Int       Date:  2006-01-25       Impact factor: 2.631

Review 2.  [Hepatitis associated cryoglobulinemia].

Authors:  S Pischke; M Cornberg; M P Manns
Journal:  Internist (Berl)       Date:  2008-03       Impact factor: 0.743

Review 3.  Viral hepatitis: past and future of HBV and HDV.

Authors:  Emmanuel Thomas; Masato Yoneda; Eugene R Schiff
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-02       Impact factor: 6.915

Review 4.  Infectious serologies and autoantibodies in hepatitis C and autoimmune disease-associated mixed cryoglobulinemia.

Authors:  Merav Lidar; Noga Lipschitz; Nancy Agmon-Levin; Pnina Langevitz; Ori Barzilai; Maya Ram; Bat-Sheba Porat-Katz; Nicola Bizzaro; Jan Damoiseaux; Jan Willem Cohen Tervaert; Salvatore deVita; Stefano Bombardieri; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

5.  Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines.

Authors:  Carla S Coffin; Scott K Fung; Mang M Ma
Journal:  Can J Gastroenterol       Date:  2012-12       Impact factor: 3.522

6.  Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study.

Authors:  Eric A Engels; Eo Rin Cho; Sun Ha Jee
Journal:  Lancet Oncol       Date:  2010-08-03       Impact factor: 41.316

Review 7.  Chronic Viral Hepatitis Is Associated with Colorectal Neoplasia: A Systematic Review and Meta-Analysis.

Authors:  Seung Wook Hong; Won-Mook Choi; Ha Won Hwang; Dae Sung Kim; Jiyoung Yoon; Jin Wook Lee; Ju Hyun Shim; Dong-Hoon Yang; Seung-Jae Myung; Suk-Kyun Yang; Jeong-Sik Byeon
Journal:  Dig Dis Sci       Date:  2021-01-12       Impact factor: 3.199

8.  Chronic hepatitis B serum promotes apoptotic damage in human renal tubular cells.

Authors:  Cun-Liang Deng; Xin-Wen Song; Hai-Jun Liang; Chen Feng; Yun-Jian Sheng; Ming-Yong Wang
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

9.  Rheumatic manifestations of hepatitis B and C and their association with viral load and fibrosis of the liver.

Authors:  Ali Aydeniz; M Namiduru; I Karaoglan; O Altindag; E Yagiz; S Gursoy
Journal:  Rheumatol Int       Date:  2009-06-18       Impact factor: 2.631

10.  Management of chronic hepatitis B: consensus guidelines.

Authors:  Morris Sherman; Stephen Shafran; Kelly Burak; Karen Doucette; Winnie Wong; Nigel Girgrah; Eric Yoshida; Eberhard Renner; Philip Wong; Marc Deschênes
Journal:  Can J Gastroenterol       Date:  2007-06       Impact factor: 3.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.